Cargando…
Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
Aim: Peritoneal dialysis is a common renal replacement method for end-stage renal disease. Long-term peritoneal dialysis leads to peritoneal dialysis-related peritoneal fibrosis, which leads to a cessation of treatment. Calpain is a protein belonging to calcium-dependent endopeptidase family and pla...
Autores principales: | Li, Fang, Wang, Yu, Tian, Jianwei, Zhou, Zhanmei, Yin, Wei, Qin, Xianhui, Wang, Huizhen, Zeng, Tao, Li, Aiqing, Jiang, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751436/ https://www.ncbi.nlm.nih.gov/pubmed/36532773 http://dx.doi.org/10.3389/fphar.2022.962770 |
Ejemplares similares
-
Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023) -
Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
por: Lu, Xiaohui, et al.
Publicado: (2023) -
Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis
por: Luo, Qimei, et al.
Publicado: (2022) -
Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022) -
Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)